161622-14-6

Basic information

• Product Name: 4-BROMO-3-(TRIFLUOROMETHYL)BENZOIC ACID
• Synonyms: Benzoic acid, 4-broMo-3-(trifluoroMethyl)-;2-Bromo-5-carboxybenzotrifluoride;2-Bromo-5-carboxybenzotrifluoride, 4-Bromo-alpha,alpha,alpha-trifluoro-m-toluic acid;4-BroMo-3-(trifluoroMethyl)benzoic acid, 95+%
• CAS NO: 161622-14-6
• Molecular Formula: C₈H₄BrF₃O₂
• Molecular Weight: 269.02
• Product Categories: Fluorine series
• Mol File: 161622-14-6.mol

Chemical Properties

• Boiling Point: 289.2 °C at 760 mmHg
• Flash Point: 128.7 °C
• Appearance: White crystalline powder
• Density: 1.773
• Vapor Pressure: 0.00103mmHg at 25°C
• Refractive Index: 1.516
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 3.54±0.10(Predicted)
• Sensitive: Light Sensitive/Air Sensitive
• CAS DataBase Reference: 4-BROMO-3-(TRIFLUOROMETHYL)BENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-(TRIFLUOROMETHYL)BENZOIC ACID(161622-14-6)
• EPA Substance Registry System: 4-BROMO-3-(TRIFLUOROMETHYL)BENZOIC ACID(161622-14-6)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 161622-14-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H4BrF3O2/c9-6-2-1-4(7(13)14)3-5(6)8(10,11)12/h1-3H,(H,13,14)

Upstream product

• 1735-53-1 4-bromo-3-(trifluoromethyl)benzonitrile 
• 623-00-7 4-bromobenzenecarbonitrile 

Downstream Products

• 107317-58-8 4-bromo-3-trifluoromethylbenzoic acid methyl ester 
• 463355-64-8 4-bromo-3-trifluoromethyl-benzoic acid ethyl ester 
• 859027-00-2 4-(4-methyl-piperazin-1-ylmethyl)-3-trifluoromethyl-benzoic acid ethyl ester 
• 859027-02-4 4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl) benzoic acid 
• 1262215-68-8 4-formyl-3-trifluoromethyl-benzoic acid ethyl ester 
• 1262215-43-9 N-(3-fluoro-4-methyl-5-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethyl-benzamide 
• 123524-61-8 4-bromo-2-(trifluoromethyl)benzamide 
• 1355159-10-2 (1R)-1-(4-{5-[2'-methyl-2-(trifluoromethyl)biphenyl-4-yl]-1,2,4-oxadiazol-3-yl}phenyl)ethanamine 
• 1355159-11-3 tert-butyl [(1R)-1-(4-{5-[2'-methyl-2-(trifluoromethyl)biphenyl-4-yl]-1,2,4-oxadiazol-3-yl}phenyl)ethyl]carbamate 
• 1355254-60-2 tert-butyl [(1R)-1-(4-{(Z)-amino[({[2'-methyl-2-(trifluoromethyl)biphenyl-4-yl]carbonyl}oxy)imino]methyl}phenyl)ethyl]carbamate 
• 1355159-86-2 tert-butyl N-[2-methoxy-1-(4-{5-[2'-methyl-2-(trifluoromethyl)biphenyl-4-yl]-1,2,4-oxadiazol-3-yl}phenyl)ethyl]-N-methylglycinate 
• 1355159-87-3 tert-butyl N-[2-hydroxy-1-(4-{5-[2'-methyl-2-(trifluoromethyl)biphenyl-4-yl]-1,2,4-oxadiazol-3-yl}phenyl)ethyl]glycinate 
• 1355159-98-6 tert-butyl N-[2-{[tert-butyl(dimethyl)silyl]oxy}-1-(4-{5-[2'-methyl-2-(trifluoromethyl)biphenyl-4-yl]-1,2,4-oxadiazol-3-yl}phenyl)ethyl]-D-alaninate 
• 1355159-99-7 tert-butyl N-[2-hydroxy-1-(4-{5-[2'-methyl-2-(trifluoromethyl)biphenyl-4-yl]-1,2,4-oxadiazol-3-yl}phenyl)ethyl]-D-alaninate 

Relevant articles and documents

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.

Silver-Catalyzed C-H Trifluoromethylation of Arenes Using Trifluoroacetic Acid as the Trifluoromethylating Reagent

Direct trifluoromethylation of arenes using TFA as the trifluoromethylating reagent was achieved with Ag as the catalyst. This reaction not only provides a new protocol for aryl C-H trifluoromethylation, but the generation of CF3· from TFA may prove useful in other contexts and could potentially be extended to other trifluoromethylation reactions. (Chemical Equation Presented).

N- (HETERO)ARYL, 2- (HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS WNT SIGNALING MODULATORS

The present invention relates to compounds of formulae 1 and 2 and methods for modulating the Wnt signaling pathway using these compounds, wherein A1, A2, B, Y and Z all represent rings.